Skip to main content
. 2022 Jun 27;21:202. doi: 10.1186/s12936-022-04225-3

Table 2.

IDIs and FGDs conducted with stakeholders

Target groups IDIs
(n = 27 respondents)
FGDs
(n = 359 respondents)
NMCP actors 03 00
Central purchasing of essential generic drugs actors 02 00
North-central region health authorities 01 00
The district management team 03 00
Head of HF 05 05
PHF drugs store managers 03 05
Health workers 00 08
Mother of children under 5 00 05
Pregnant women 00 04
Head of household 00 05
Adult men 00 05
Community leaders 10 04
Total 27 41

FGD focus group discussion; IDI in-depth individual interviews